- Type / Class
- Equity / Common Stock
- Shares outstanding
- 39,581,465
- Total 13F shares
- 35,918,321
- Share change
- +2,831,880
- Total reported value
- $400,488,868
- Price per share
- $11.15
- Number of holders
- 156
- Value change
- +$22,756,116
- Number of buys
- 97
- Number of sells
- 59
Quarterly Holders Quick Answers
What is CUSIP 68752M108?
CUSIP 68752M108 identifies OFIX - Orthofix Medical Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68752M108:
Top shareholders of OFIX - Orthofix Medical Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Engine Capital Management, LP |
13F
|
Company |
9.5%
|
3,741,390
|
$61,022,071 | — | 31 Mar 2025 | |
| ENGINE CAPITAL, L.P. |
13D/G
|
Engine Capital Management, LP |
11%
|
4,251,671
|
$60,331,211 | +$8,846,670 | 07 May 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
9.3%
|
3,694,946
|
$60,264,569 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.7%
from 13D/G
|
3,062,197
|
$49,944,436 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
7.5%
from 13D/G
|
2,964,000
|
$48,342,840 | — | 31 Mar 2025 | |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
|
Company |
6.3%
|
2,481,700
|
$40,476,527 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.5%
|
2,181,313
|
$35,577,214 | — | 31 Mar 2025 | |
| Juniper Investment Company, LLC |
13F
|
Company |
5.4%
|
2,137,374
|
$34,860,570 | — | 31 Mar 2025 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.4%
|
948,202
|
$15,465,175 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
865,464
|
$14,119,455 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
860,340
|
$14,032,145 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.1%
|
812,268
|
$13,246,953 | — | 31 Mar 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
2%
|
811,138
|
$13,229,653 | — | 31 Mar 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.5%
|
601,925
|
$9,817,397 | — | 31 Mar 2025 | |
| AYAL Capital Advisors Ltd |
13F
|
Company |
1.4%
|
539,770
|
$8,803,649 | — | 31 Mar 2025 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
1.3%
|
514,524
|
$8,391,886 | — | 31 Mar 2025 | |
| Philosophy Capital Management LLC |
13F
|
Company |
0.94%
|
370,763
|
$6,047,145 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.88%
|
350,152
|
$5,710,981 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.82%
|
324,847
|
$5,298,255 | — | 31 Mar 2025 | |
| Keith Valentine |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
377,741
|
$5,156,165 | — | 28 Feb 2023 | |
| Jon Carl Serbousek |
3/4/5
|
Executive Chairman, Director |
—
class O/S missing
|
346,827
|
$4,734,189 | — | 03 Apr 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.57%
|
224,820
|
$3,666,833 | — | 31 Mar 2025 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.5%
|
197,551
|
$3,222,057 | — | 31 Mar 2025 | |
| Kimberley A. Elting |
3/4/5
|
President, Global Orthopedics |
—
mixed-class rows
|
271,614
mixed-class rows
|
$3,056,365 | — | 08 Jun 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.46%
|
180,567
|
$2,945,048 | — | 31 Mar 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.46%
|
180,303
|
$2,941,000 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.45%
|
178,213
|
$2,906,651 | — | 31 Mar 2025 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.45%
|
177,471
|
$2,894,552 | — | 31 Mar 2025 | |
| Stuart Essig |
3/4/5
|
Director |
—
class O/S missing
|
205,966
|
$2,811,436 | — | 05 Jan 2023 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.43%
|
169,530
|
$2,765,034 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
168,740
|
$2,752,150 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.42%
|
167,426
|
$2,730,719 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.41%
|
161,423
|
$2,632,809 | — | 31 Mar 2025 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.4%
|
157,100
|
$2,562,301 | — | 31 Mar 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.38%
|
150,500
|
$2,454,655 | — | 31 Mar 2025 | |
| Kevin J. Kenny |
3/4/5
|
President of Global Spine |
—
class O/S missing
|
145,810
|
$1,990,307 | — | 08 Jan 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
107,595
|
$1,754,882 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
105,495
|
$1,720,624 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.26%
|
103,334
|
$1,685,377 | — | 31 Mar 2025 | |
| Catherine M. Burzik |
3/4/5
|
Director |
—
class O/S missing
|
112,803
|
$1,605,187 | — | 08 Apr 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.25%
|
97,879
|
$1,596,406 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.25%
|
97,647
|
$1,592,623 | — | 31 Mar 2025 | |
| HighVista Strategies LLC |
13F
|
Company |
0.23%
|
92,900
|
$1,515,199 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
91,990
|
$1,500,357 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.23%
|
90,503
|
$1,476,104 | — | 31 Mar 2025 | |
| Rice Doug |
3/4/5
|
CFO |
—
class O/S missing
|
107,679
|
$1,469,818 | — | 11 Apr 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.23%
|
89,059
|
$1,452,552 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.22%
|
88,620
|
$1,445,392 | — | 31 Mar 2025 | |
| Keeley-Teton Advisors, LLC |
13F
|
Company |
0.21%
|
83,657
|
$1,364,446 | — | 31 Mar 2025 | |
| John J. Bostjancic |
3/4/5
|
CFO |
—
class O/S missing
|
99,670
|
$1,360,496 | — | 28 Feb 2023 |
Institutional Holders of Orthofix Medical Inc. - Common Stock (OFIX) as of Q2 2025
As of 30 Jun 2025,
Orthofix Medical Inc. - Common Stock (OFIX) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,918,321 shares.
The largest 10 holders included
Engine Capital Management, LP, Rubric Capital Management LP, PARADIGM CAPITAL MANAGEMENT INC/NY, BlackRock, Inc., ARMISTICE CAPITAL, LLC, Juniper Investment Company, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, and AYAL Capital Advisors Ltd.
This page lists
157
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
158
Q2 2025 holders
156
Holder diff
-2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.